Kanwaljit Rana | Bioinformatics in Pharmaceuticals | Best Researcher Award

Published on by Top Pharmaceutical

Kanwaljit Rana | Bioinformatics in Pharmaceuticals | Best Researcher Award

Dr Kanwaljit Rana,Guru Angad Dev Veterinary and Animal Sciences University, Ludhiana, Punjab, India, India

Dr. Kanwaljit Rana πŸ§¬πŸ“Š is a health researcher specializing in computational biology and big data analytics for disease diagnosis and health outcome prediction. Holding a Ph.D. in Biotechnology from GADVASU, India (2022), Dr. Rana integrates large-scale clinical, biological, and omics data using machine learning for precision medicine. With research experience at ICGEB and PGIMER, he has developed bioinformatics pipelines for genomics and predictive health analytics. His expertise spans AI-driven diagnostics, wearable health tech, and big data automation. A published scientist and GATE-qualified scholar, Dr. Rana continues to innovate in health data science and computational medicine. πŸš€

Publication Profile

Google scholar

Education

Dr. Kanwaljit Rana πŸŽ“ holds a Ph.D. in Biotechnology from Guru Angad Dev Veterinary and Animal Sciences University (GADVASU), India (2022). With a strong academic foundation, he previously earned a Master’s degree in Biotechnology from HNB Garhwal University, Srinagar. His expertise lies in cutting-edge biotechnological research, contributing to advancements in veterinary and animal sciences πŸ§¬πŸ”¬. Passionate about innovation and scientific discovery, Dr. Rana continues to explore new frontiers in biotechnology, striving to make a meaningful impact in the field. His dedication to research and development reflects his commitment to scientific excellence and progressive learning

Professional Experience

Dr. Kanwaljit Rana πŸŽ“ is a dedicated Research Associate at the International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi (Feb 2024 – Aug 2024), where he conducts advanced bioinformatics analysis 🧬, integrating genomics and metagenomics data for disease characterization. Previously, at PGIMER, Chandigarh (Sep 2022 – Jan 2023), he developed automated workflows for tuberculosis meningitis diagnosis πŸ₯. His research journey includes roles at Punjab Agricultural University (PAU), Ludhiana, and Swami Vivekanand Faculty of Technology & Management, specializing in molecular breeding 🌱 and agricultural biotechnology. He is also a QC Freelancer at Cactus Communications since October 2024 ✍️.

Awards

Dr. Kanwaljit Rana πŸŽ“ is a highly accomplished researcher, having qualified GATE Biotechnology in both 2020 and 2022 πŸ†, showcasing his expertise in the field. His dedication to innovative research earned him the Best Poster Award πŸ₯‡ for his work on “Boon of Cow Curd Consumption” at the National Webinar on Cowpathy and Animal Health (2021) πŸ„πŸ§ͺ. His contributions to biotechnology and health sciences continue to make a significant impact, blending traditional knowledge with modern scientific advancements. Dr. Rana remains committed to groundbreaking research and advancements in biotechnology and health sciences πŸ”¬πŸ“š

Research Focus

Dr. Kanwaljit Rana’s research primarily focuses on computational genomics 🧬, bioinformatics πŸ–₯️, and veterinary genetics 🐢. His work involves biocomputational analysis of microRNAs, genome assembly, and ancestry studies, particularly in indigenous dog breeds like the Gaddi dog. His expertise extends to genome sequencing, phylogenetics, and the application of programming languages like Python, R, and MATLAB for data analysis. His contributions to veterinary science include genetic insights into animal breeding, evolution, and conservation. Through his interdisciplinary approach, Dr. Rana advances animal genomics, computational biology, and veterinary research, impacting both genetic conservation and bioinformatics applications in animal sciences.

Publication Top Notes

Differential Perspectives Between miRNA and lncRNA in Light of Biogenesis and Functions: A Review

Molecular characterization of indigenous dogs through whole genome analysis

Biocomputational identification of microRNAs from indigenous Gaddi dog genome

Introduction to Python, R, and MATLAB

Chuan Fan | Nanomedicine | Best Researcher Award

Published on by Top Pharmaceutical

Chuan Fan | Nanomedicine | Best Researcher Award

Dr Chuan Fan,Linyi University,China

Dr. Chuan Fan πŸŽ“πŸ”¬ is a lecturer at Linyi University’s School of Chemistry and Chemical Engineering, specializing in multifunctional hydrogel dressing systems and acoustic-driven biomarker analysis. He earned his degree from the University of Science and Technology Beijing under Prof. Xueji Zhang. With 30+ SCI- and Scopus-indexed publications and a ResearchGate citation index of 984, his research contributes to pharmacology and drug delivery. However, he is in the early stages of securing patents, grants, and industry collaborations. His work holds promise for advanced therapeutic applications, making him a strong contender for early-career research awards. πŸ†πŸ“š

Publication Profile

Scopus

Academic and Professional Background

Dr. Chuan Fan πŸŽ“ pursued his studies at the University of Science and Technology Beijing under the esteemed mentorship of Professor Xueji Zhang. Since August 2023, he has been serving as a lecturer at Linyi University’s School of Chemistry and Chemical Engineering 🏫. His research primarily focuses on multifunctional hydrogel dressing systems and acoustic-driven enrichment analysis of trace biomarkers πŸ§ͺ. Through his dedication and innovation, Dr. Fan has made significant progress in his field, contributing to multiple high-quality publications in indexed journals πŸ“š. His work continues to advance scientific knowledge and practical applications in chemical and biomedical research. πŸš€

Research and Innovations

Dr. Chuan Fan has made notable contributions to his field, authoring over 30 SCI- and Scopus-indexed articles πŸ“„, reflecting his dedication to research. His citation index on ResearchGate stands at 984 πŸ”, indicating a moderate academic impact. However, his research engagement appears to be in its early stages, with no completed projects and only two ongoing ones πŸ§ͺ. Despite his publication record, he has yet to secure patents, editorial appointments, industry collaborations, consultancy projects, or book publications πŸ“š. While his work is promising, further achievements in these areas could enhance his influence in the scientific community. 🌟

Contributions and Impact

Dr. Chuan Fan is dedicated to advancing pharmacology and drug delivery systems, with a focus on enhancing targeted therapies and improving patient outcomes πŸ’ŠπŸ”¬. His research explores innovative methods to optimize drug efficacy and minimize side effects, contributing to the evolving landscape of precision medicine. While he asserts that his work has gained significant recognition, concrete evidence such as prestigious awards, keynote invitations, or high-impact citations remains unspecified πŸ†πŸ“–. Despite this, his contributions reflect a commitment to revolutionizing drug delivery, potentially shaping future advancements in personalized treatment strategies for various medical conditions πŸš€πŸ§¬.

Professional Engagements

Dr. Chuan Fan currently does not hold any professional memberships, editorial roles, or collaborative positions, which are key indicators of a researcher’s influence in the academic community πŸ“š. Actively participating in international conferences 🌍, joining professional societies πŸ›οΈ, and engaging in research networks πŸ”¬ would significantly enhance his professional standing. Such involvement fosters knowledge exchange, strengthens collaborations, and increases visibility within the scientific community. By contributing to peer-reviewed journals ✍️, networking with experts 🀝, and taking on leadership roles, Dr. Fan can expand his impact and establish himself as a recognized authority in his field of expertise.

Research Focus

Dr. Chuan Fan’s research focuses on biomedical materials πŸ§ͺ, nanotechnology 🧫, and wound healing 🩹, particularly in developing visible light-activated Ti-MOF (titanium-metal-organic frameworks) hydrogel composites for chronic diabetic wound healing 🦢. His work integrates photocatalysis 🌞, drug delivery πŸ’Š, and biocompatible hydrogels to enhance tissue regeneration and antimicrobial effects. By loading metformin into these advanced biomaterials, Dr. Fan aims to promote faster and more effective healing of diabetic wounds, addressing a critical medical challenge. His research sits at the intersection of materials science πŸ—οΈ, biomedical engineering βš™οΈ, and regenerative medicine 🧬.

Publication Top Notes

Visible light-activated Ti-MOF loaded metformin-hydrogel composite dressing for accelerated chronic diabetic wound healing

Ndzembanteh Aboubakary Nulambeh | Pharmacogenomics | Best Researcher Award

Published on by Top Pharmaceutical

Ndzembanteh Aboubakary Nulambeh | Pharmacogenomics | Best Researcher Award

Dr Ndzembanteh Aboubakary Nulambeh, The University of Bamenda, Cameroon

Dr. Ndzembanteh Aboubakary Nulambeh πŸ‡¨πŸ‡² is a seasoned economist with over eight years of experience in academia and research. He holds a PhD in International Economics from Bursa Uludag University, Turkey, and an MSc in Economics from the International Islamic University of Malaysia. Currently, he serves as an Assistant Lecturer at the Higher Institute of Management Studies and ISTGAC Maaron University Institute in Cameroon. His expertise includes macro & microeconometrics, sustainable finance, and Islamic economics. With multiple publications in high-impact journals, he actively researches green growth, climate neutrality, and financial development. Dr. Ndzembanteh is fluent in English and proficient in French.

Publication Profile

orcid

Educational Background

Dr. Ndzembanteh Aboubakary Nulambeh is a distinguished economist with a strong academic background πŸ“š. He earned his PhD in International Economics from Bursa Uludag University, Turkey, in September 2020 πŸŽ“. Prior to that, he completed his Master of Science in Economics at the International Islamic University of Malaysia in January 2015 🌍. His academic journey began with a Bachelor of Science in Economics from the University of YaoundΓ© 2, Soa, Cameroon, in October 2009 πŸ“ˆ. With expertise in economic research and analysis, Dr. Ndzembanteh continues to contribute to the field with valuable insights and global perspectives 🌎.

Award Achievements

Dr. Ndzembanteh Aboubakary Nulambeh is dedicated to providing quality education to undergraduate students πŸŽ“. He meticulously prepares lesson plans and lecture notes πŸ“š to ensure a structured and engaging learning experience. Additionally, he designs tutorial worksheets and exam papers ✍️ to assess students’ understanding effectively. Beyond teaching, he takes on essential administrative tasks 🏒, contributing to curriculum development to enhance academic programs. His commitment to academic excellence fosters a productive learning environment, equipping students with the necessary knowledge and skills for success. Through his efforts, he plays a vital role in shaping future professionals in his field 🌟.

Conferences And Seminars

Dr. Ndzembanteh Aboubakary Nulambeh has made significant contributions to economic and environmental research. His study, The Role of Financial Development, Education, and Economic Growth on Environmental Quality in Cameroon (Istanbul Finance Conference, 2020), explores how financial progress and education influence environmental sustainability πŸŒ±πŸ“ˆ. Another key work, An Empirical Analysis of the Environmental Kuznets Curve: The Case of Cameroon (Uludağ University, 2019), examines the relationship between economic growth and environmental degradation πŸ“ŠπŸŒ. Additionally, his research on The Impact of Human Capital and Innovation Output on Economic Growth compares Malaysia and Turkey, highlighting the role of knowledge and creativity in economic progress πŸ’‘πŸš€.

Teaching and Mentorship

Dr. Ndzembanteh Aboubakary Nulambeh has a wealth of teaching experience across various institutions, including the Higher Institute of Management Studies, ISTGAC Maaron University Institute, and UNITAR International University. πŸ“š He has taught a range of subjects such as macro and microeconomics, statistics, mathematical economics, and sustainable finance, inspiring students in the field of economics. πŸ’‘ His dedication to education extends beyond teaching, as he actively guides students in research, fostering the next generation of economists. πŸ§‘β€πŸŽ“ Additionally, his contributions to curriculum development highlight his commitment to enhancing academic programs in economics.

Research Focus

Dr. Ndzembanteh Aboubakary Nulambeh’s research focuses on the energy-environment nexus, economic growth, and development in sub-Saharan Africa. His studies address environmental economics, energy policy, financial development, trade openness, and foreign direct investment. He explores how these factors influence economic growth, environmental quality, and human capital. His work also examines the role of institutions in fostering sustainable development, innovation, and agricultural sector financing. πŸŒπŸ“ŠπŸ’‘πŸ“šπŸ’ΌπŸ”‹πŸŒ±

Publication Top Notes

Could industrialization and renewable energy enhance environmental sustainability: An empirical analysis for Sub-Saharan Africa?

Modeling the role of institutions on poverty and environmental sustainability: a panel analysis for British and French ex-colonies in Africa

Exploring the energy-environment growth nexus in francophone Africa in presence of institutions

The Role of Renewable Energy and Ecological Footprint on Economic Growth in Francophone African Countries in presence of Institutions

An Empirical Analysis of the Environmental Kuznets Curve: The Case of Cameroon

THE ROLE OF FINANCIAL DEVELOPMENT, EDUCATION AND ECONOMIC GROWTH ON ENVIRONMENTAL QUALITY IN CAMEROON

The role of financial development, human capital, and economic growth on environmental sustainability: an empirical analysis of Cameroon

Ms. Frezer Kedir|Personalized Medicine|Women Researcher Award

Published on by Top Pharmaceutical

Ms. Frezer Kedir-Personalized Medicine-Women Researcher Award

Ms. Frezer Kedir at Institute of Health, Jimma University, Ethiopia

Author Profile

Early Academic Pursuits πŸŽ“

Frezer Kedir Menu’s academic journey began with a strong foundation in primary education at Ingibi Elementary School and Ras Tesema Nado Elementary School. She demonstrated early promise, which propelled her to pursue her secondary education at Bedele Secondary School, completing it with distinction.

Frezer’s higher education commenced at KE-MED Medical College, where she acquired foundational medical knowledge between 1998 and 2001. Building on her passion for healthcare and academic excellence, she enrolled at Jimma University, earning a Bachelor of Science (BSc) degree in 2016. Driven by her unwavering commitment to advancing her knowledge and skills, she pursued a Master’s degree in Adult Health Nursing at the same university, completing it in 2024 with a commendable GPA of 3.64.

Professional Endeavors πŸ’Ό

Frezer has accumulated over 12 years of hands-on experience in clinical healthcare, showcasing her dedication to patient care and medical excellence. She is currently serving as a Program Facilitator, a role that involves designing, implementing, and overseeing healthcare programs to ensure maximum impact. Her work reflects a deep understanding of clinical protocols and the ability to address complex health challenges in diverse settings.

Her career is not only defined by her clinical acumen but also by her commitment to fostering positive patient outcomes and empowering healthcare teams. Frezer’s experience in facilitating programs underscores her strong leadership capabilities and ability to drive organizational objectives effectively.

Contributions and Research Focus πŸ§ͺ

Frezer’s research contributions highlight her dedication to addressing critical healthcare issues in Ethiopia. Her work spans a range of topics that directly impact patient care and public health, including:

  1. Dietary Knowledge and Its Associated Factors Among Diabetic Patients (2016):
    A study aimed at understanding dietary knowledge among diabetic patients at Jimma Medical Center, emphasizing the importance of nutrition in managing diabetes.
  2. Unmet Supportive Care Needs Among Cancer Patients (2023):
    This research explored the gaps in supportive care for cancer patients, providing insights into improving palliative care and patient support systems.
  3. Patient Engagement in Healthcare Decision-Making (2023):
    A project examining how patients with chronic non-communicable diseases in Southern Ethiopia engage in healthcare decisions, highlighting the significance of shared decision-making.
  4. Patient Autonomy in Managing Brachial Asthma (2024):
    This study focused on promoting patient autonomy and self-management in asthma care, offering strategies for better healthcare delivery in Southern Ethiopia.

Accolades and Recognition πŸ†

Frezer’s work has earned her several certifications and accolades, which attest to her professional commitment and continuous growth. Notable achievements include:

  • Leadership Training Certificate: Demonstrating her ability to lead and train healthcare teams effectively.
  • PMTCT Training: Equipping her with essential skills to prevent mother-to-child transmission of diseases.
  • CISCO Certification: Enhancing her technical competencies in basic computer skills.
  • Operational Smile Training: Recognizing her contribution to healthcare training programs.
  • Developmental Team Training Certificate: Reflecting her focus on team-building and operational efficiency.

Impact and Influence 🌍

Frezer’s contributions extend beyond research and clinical work. Her role as a program facilitator allows her to influence healthcare delivery systems, ensuring they are inclusive and patient-centered. Through her research, she has shed light on critical healthcare gaps, prompting improvements in dietary education, supportive care, patient autonomy, and engagement in decision-making processes.

Legacy and Future Contributions 🌟

Frezer’s dedication to healthcare is creating a legacy of improved patient outcomes and enhanced healthcare systems in Ethiopia. Her research continues to inspire evidence-based practices, and her leadership in program facilitation fosters a culture of excellence within her teams.

In the future, Frezer aims to expand her impact by contributing to national healthcare policies, mentoring young professionals, and advocating for research-driven solutions to pressing healthcare challenges. She envisions a healthcare system that is both accessible and equitable, ensuring that every patient receives the care they deserve.

Notable Publications

Engagement in healthcare decision-making and associated factors among patients with chronic non-communicable diseases in Southwest Ethiopia

  • AuthorsΒ  Β : Abdulwehab, S., Belay, Y., Kedir, F., Yimam, E., Belay, A.
  • YearΒ  Β  Β  Β  Β :2024

Patient autonomy in self-managing their bronchial asthma exacerbation and its associated factors,

      • AuthorsΒ  Β : Abdulwehab, S., Kedir, F.
      • YearΒ  Β  Β  Β  Β :2024

       

Mr. Sadik Abdulwehab|Personalized Medicine|Top Pharmaceutical Scientist Award

Published on by Top Pharmaceutical

Mr. Sadik Abdulwehab-Personalized Medicine-Top Pharmaceutical Scientist Award

Mr. Sadik Abdulwehab at Wallaga University, Ethiopia

Author Profile

Orcid

Early Academic Pursuits πŸŽ“

Sadik Abdulwehab Wake began his academic journey with a strong foundation in his hometown, Ethiopia. His primary education was completed at Oda Dannisa Elementary School (2001-2009), followed by secondary education at Digalu Secondary School (2010-2012). Demonstrating academic excellence, he progressed to Sagure Preparatory School in 2012-2013. He then embarked on his higher education at Wallega University, where he earned his Bachelor of Science (BSc) in Nursing in 2017 with an impressive cumulative GPA of 3.94.

His thirst for knowledge led him to pursue a Master’s degree in Adult Health Nursing (AHN) at Jimma University, which he successfully completed in 2024, achieving another remarkable GPA of 3.92. Currently, he is advancing his scholarly pursuits as a Ph.D. fellow, reflecting his dedication to continuous learning and academic excellence.

Professional Endeavors πŸ₯

Sadik has accumulated over six years of professional experience, including three and a half years in clinical nursing practice and three years in academia. During his clinical tenure, he honed his expertise in patient care, especially in adult health nursing, ensuring the delivery of high-quality healthcare services.

In the academic realm, Sadik has excelled as a lecturer, sharing his knowledge and inspiring the next generation of nursing professionals. His commitment to education is evident in his involvement in mentoring and supervising students on various research projects.

Sadik also contributed to national and international research efforts, collecting data for multiple NGOs and earning recognition for his contributions. His ability to blend clinical experience with academic prowess sets him apart as a multifaceted nursing professional.

Contributions and Research Focus πŸ”¬

Sadik’s research interests span various critical areas in healthcare. His notable projects include:

  1. Blood Donation Awareness: Investigated the knowledge, attitude, and practice of medical and health science students at Wollega University regarding blood donation (2017).
  2. Patient Engagement in Decision-Making: Explored factors influencing patient involvement in healthcare decision-making at Jimma Medical Center (2023).
  3. Patient Autonomy in Asthma Management: Analyzed autonomy levels in managing bronchial asthma and associated factors at JMC (2023).
  4. Erectile Dysfunction in Type 1 Diabetes Patients: Studied its prevalence and associated factors among T1DM patients at JMC (2023).
  5. Workplace Violence in Nursing: Conducted a systematic review and meta-analysis on workplace violence against nurses in Ethiopia (2024).

These research endeavors demonstrate Sadik’s commitment to addressing significant challenges in nursing and healthcare, ultimately aiming to improve patient outcomes and the nursing profession.

Accolades and Recognition πŸ…

Sadik’s dedication to his field has earned him numerous accolades, including:

  • Recognition letters and certificates for his contributions as a data collector for NGO projects.
  • Certification for completing a masterclass course with exceptional performance, further enhancing his professional credentials.

Impact and Influence 🌍

Sadik’s contributions have had a profound impact on healthcare and academia in Ethiopia. Through his research, he has provided valuable insights into critical issues such as patient autonomy, workplace violence in nursing, and healthcare decision-making. His work serves as a foundation for policy development and practical interventions to improve healthcare delivery.

In academia, his mentorship has guided many nursing students toward achieving their academic and professional goals. His influence extends beyond the classroom, shaping the future of nursing in Ethiopia.

Legacy and Future Contributions 🌟

As a Ph.D. fellow, Sadik aims to continue his journey of scholarly excellence and professional impact. His future goals include:

  • Advancing research in adult health nursing and other critical areas of healthcare.
  • Developing innovative solutions to address workplace challenges faced by nurses.
  • Contributing to global healthcare through collaborative research and knowledge exchange.

Sadik Abdulwehab Wake’s legacy lies in his unwavering commitment to nursing, education, and research. His journey inspires countless others to strive for excellence in the pursuit of improving lives through healthcare.

Closing Thoughts πŸ’‘

With a proven track record of academic achievements, professional expertise, and impactful research, Sadik embodies the qualities of a visionary nursing leader. His aspirations align with his commitment to serving society and advancing the nursing profession, making him an invaluable asset to any institution or organization.

Notable Publication

Engagement in healthcare decision-making and associated factors among patients with chronic non-communicable diseases in Southwest Ethiopia, 2023

  • AuthorsΒ  Β : Sadik Abdulwehab; Yeshitila Belay; Frezer Kedir; Ebrahim Yimam; Admasu Belay
  • JournalΒ  Β  : Epidemiology and Global Health
  • YearΒ  Β  Β  Β  Β :2024

Patient autonomy in self-managing their bronchial asthma exacerbation and its associated factors, 2024

      • AuthorsΒ  Β : adik Abdulwehab;Β Frezer Kedir
      • JournalΒ  Β  : Allergy
      • YearΒ  Β  Β  Β  Β :2024

Erectile Dysfunction and Associated Factors among Adult Diabetic Patients in Jimma Medical Center, Southwest, Ethiopia, 2023

  • AuthorsΒ  Β : adik Abdulwehab

 

Prof. Dr. Federico Hawkins|Personalized Medicine|Excellence in Research

Published on by Top Pharmaceutical

Prof. Dr. Federico Hawkins-Personalized Medicine-Excellence in Research

Prof. Dr. Federico Hawkins at Universidad Complutense Madrid ,Spain

Author Profile

Scopus

πŸŽ“ Early Academic Pursuits

Federico Gilberto Hawkins Carranza embarked on a remarkable academic journey in the field of medicine, earning his General Physician degree from the University of Salamanca in 1969. This was followed by his pursuit of higher education, where he completed a Ph.D. thesis titled β€œMechanism of Action of Gastrointestinal Hormones upon Pancreas” under the mentorship of Prof. Dr. Manuel Serrano RΓ­os at the University AutΓ³noma of Madrid in 1978.

During this period, Dr. Hawkins also obtained a Diploma in Psychology from the Pontifical University of Salamanca (1969) and completed his Internship and Residency at FundaciΓ³n JimΓ©nez DΓ­az (1969–1972), specializing in Internal Medicine and Endocrinology in 1973. His thirst for knowledge led him to prestigious institutions worldwide through scholarships, including the Endocrine Unit at Hammersmith Hospital in London (1977) and the Transplant Unit at Minnesota University (1980).

πŸ’Ό Professional Endeavors

Dr. Hawkins began his illustrious career as a physician in the Service of Endocrinology at University Hospital 12 de Octubre, Madrid, in 1973. By 1979, he rose to the position of Chief of Service of Endocrinology, a role he held until 2016. His contributions to clinical endocrinology were instrumental in shaping the department into a hub of innovation and excellence.

Parallel to his clinical work, Dr. Hawkins was an active academician. In 1978, he was appointed Professor of Medicine at Complutense University of Madrid and eventually became the Chairman of Medicine in 2000. Post-retirement, he continued to serve as a Consultant at the Research Institute i+12 at University Hospital 12 de Octubre.

πŸ”¬ Contributions and Research Focus

Dr. Hawkins made pioneering contributions to endocrinology, focusing on diabetes, thyroid diseases, and postmenopausal osteoporosis.

Diabetes Mellitus:

  • Developed and implemented Radioimmunoassays (RIA) for insulin and glucagon in Spain.
  • Conducted studies on insulin secretion in chromosomal disorders, including Klinefelter’s and Down syndromes.
  • Demonstrated the hypoglycemic effects of fig tree decoctions in animals and humans.

Thyroid Diseases:

  • Advanced the understanding of thyrocalcitonin fractions in neoplasia and thyroid cancer.
  • Investigated the relationship between TSH suppression and bone mass.

Postmenopausal Osteoporosis:

  • Played a key role in clinical trials for drugs such as Alendronate, Risedronate, Teriparatide, and Strontium Ranelate.
  • Actively participated in drafting the Spanish Guide for Osteoporosis, contributing to patient care protocols.

πŸ† Accolades and Recognition

Dr. Hawkins’ expertise and leadership were widely acknowledged:

  • He was appointed as an Academician Correspondent at the Royal Academy of Medicine in 2017.
  • Received honorary titles such as Extraordinary Professor at the Faculty of Medicine in Panama (2016).
  • Served as the Director of the Revista EspaΓ±ola de Enfermedades MetabΓ³licas and a reviewer for prestigious journals, including Current Medical Research & Opinion.

🌍 Impact and Influence

Dr. Hawkins significantly influenced the global medical community through his research and teaching. His studies on bone mass in diabetics and early markers of bone loss have been foundational in advancing treatment strategies. As an academician, he nurtured generations of physicians and researchers, promoting excellence in clinical endocrinology.

πŸ›οΈ Legacy and Future Contributions

Even in retirement, Dr. Hawkins remains a towering figure in endocrinology. His dedication to patient care, innovative research, and teaching has left a lasting legacy. His work on endocrine disorders, especially diabetes and osteoporosis, continues to shape clinical practices worldwide. Dr. Hawkins also actively contributes to medical guidelines and collaborates with researchers globally, ensuring his insights continue to benefit humanity.

Notable Publication

Socioeconomic status, osteoporosis and fragility fractures | Estatus socioeconΓ³mico, osteoporosis y fracturas por fragilidad

  • AuthorsΒ  Β : MartΓ­nez-DΓ­az-Guerra, G., Hawkins Carranza, F., Librizzi, S.
  • YearΒ  Β  Β  Β  Β :2024

Health-Related Quality of Life Long-Term Study in Lung Transplant Patients: A Single-Center Experience

      • AuthorsΒ  Β : Monteagudo, L.J., Diaz-Guerra, G.M., Badillo, A.Á., … Arriscado, C.M., Hawkins Carranza, F.
      • YearΒ  Β  Β  Β  Β :2024

Comparison of Bone Mineral Density and Trabecular Bone Score in Patients with and without Vertebral Fractures and Differentiated Thyroid Cancer with Long-Term Serum Thyrotrophin-Suppressed Therapy

  • AuthorsΒ  Β : Hawkins Carranza, F., Arroba, C.M.-A., LΓ³pez Alvarez, M.B., Librizzi, S., MartΓ­nez DΓ­az Guerra, G.
  • JournalΒ  Β  : Diagnostics
  • YearΒ  Β  Β  Β  Β :2024

Incidence of type 2 diabetes in the elderly in Central Spain: Association with socioeconomic status, educational level, and other risk factors

  • AuthorsΒ  Β :Hawkins Carranza, F., CorbatΓ³n-Anchuelo, A., Bermejo Pareja, F., … Benito-LeΓ³n, J., Serrano-RΓ­os, M.
  • JournalΒ  Β  Β : Primary Care Diabetes
  • YearΒ  Β  Β  Β  Β :2022Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β Β 

Association of Low Serum 25OHD Levels with Abnormal Bone Microarchitecture in Well-Differentiated Thyroid Cancer

  • AuthorsΒ  Β :Hawkins Carranza, F., Guadalix Iglesias, S., De Mingo Dominguez, M.L., … Alvares, B.L., MartΓ­nez Diaz-Guerra, G.

Dr. Alberto Camacho Morales|Personalized Medicine|Excellence in Researchd

Published on by Top Pharmaceutical

Dr. Alberto Camacho Morales|Personalized Medicine|Excellence in Research

Dr. Alberto Camacho Morales at Abdul wali khan university mardan,Pakistan

PROFILEΒ Β 

 

Google scholar

Orcid

scopus.

Early Academic Pursuits πŸŽ“

Alberto Camacho Morales’s academic journey is a testament to his dedication to biomedical sciences. After earning a Bachelor’s degree in Biology from the Faculty of Sciences at the National Autonomous University of Mexico (UNAM) in 1999, he pursued advanced studies with unwavering focus. Driven by a passion for understanding cellular processes, he completed a Ph.D. in Biomedical Sciences at the Institute of Cellular Physiology (UNAM) in 2007. His doctoral research laid a strong foundation for his specialization in metabolic and neurophysiological sciences. Alberto’s pursuit of academic excellence culminated in a postdoctoral fellowship at the Institute of Metabolic Science, University of Cambridge, England (2007–2011). These experiences solidified his expertise in metabolic programming, a field where he has become a pioneering voice.

Professional Endeavors 🏒

Since completing his postdoctoral studies, Dr. Camacho Morales has held several influential roles in academia and research. He began his teaching career as a professor-researcher at the School of Medicine, TecnolΓ³gico de Monterrey (2011). By 2012, he transitioned to the Faculty of Medicine, Autonomous University of Nuevo LeΓ³n (UANL), where he assumed roles that included leading molecular and biochemical studies and coordinating critical academic programs for graduate and undergraduate students.

Dr. Camacho has also extended his expertise beyond academia as a President and Member of Biosecurity and Research Committees at Accelerium Clinical Research, a testament to his ability to bridge research and its practical applications in clinical settings. His 17+ years of professional experience in translational science have equipped him to consult and guide preclinical and clinical research projects effectively.

Contributions and Research Focus 🧠

Dr. Camacho Morales’s research contributions have significantly impacted the understanding of metabolic disorders and neurophysiological programming. His primary areas of research include:

Maternal Neuroinflammation and Behavioral Disorders: Investigating how maternal obesity during pregnancy programs neuroinflammation, contributing to behavioral abnormalities in offspring.
Neuronal Plasticity and Addiction: Understanding the role of neuronal plasticity in hypercaloric food addiction and its implications in obesity development.
Metabolic Programming During Pregnancy: Exploring how prenatal metabolic programming influences metabolic and behavioral outcomes in offspring.
Biomarkers of Metabolic Damage: Identifying blood biomarkers associated with metabolic damage in obese individuals, with and without Type 2 diabetes.
Dr. Camacho’s research combines cutting-edge methodologies in molecular biology, neuroscience, and endocrinology, addressing global challenges like obesity, diabetes, and neuropsychiatric disorders.

Accolades and Recognition πŸ†

Dr. Camacho Morales’s exemplary work has earned him numerous awards and recognitions:

National Researcher Level III (2024): A prestigious distinction from Mexico’s National System of Researchers.
First Place in Basic Science Research (2023): UANL acknowledged his groundbreaking work in metabolic programming.
Multiple accolades at state and national levels, including awards in research competitions (e.g., Funsalud Prize for Basic Research in 2018).
Marie Curie Postdoctoral Fellowship: A two-year fellowship at the University of Cambridge, funded by the European Union.
His sustained commitment to scientific excellence is also evident in his editorial roles for esteemed journals like Frontiers in Endocrinology and Molecular Psychiatry.

Impact and Influence 🌍

As a leader in his field, Dr. Camacho Morales has made significant contributions to the academic community. His roles as a professor and mentor at UANL have inspired countless students to pursue careers in biomedical sciences. He coordinates critical courses in molecular biology, biochemistry, and cellular biology for master’s and doctoral programs, shaping future researchers’ perspectives.

His editorial and peer-review roles for high-impact journals, such as Diabetes and Molecular Neuroscience, demonstrate his influence in advancing global biomedical research. By reviewing and editing scientific literature, he has contributed to the integrity and progression of his field.

Legacy and Future Contributions 🌱

Dr. Camacho Morales’s work has lasting implications for understanding and treating metabolic and neurophysiological disorders. His research on the programming of metabolic and behavioral outcomes in offspring provides valuable insights for developing preventive and therapeutic strategies.

 

πŸŽ“PublicationΒ 

Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice

  • AuthorsΒ  Β : Xavier Prieur, Crystal YL Mok, Vidya R Velagapudi, Vanessa NΓΊΓ±ez, LucΓ­a Fuentes, David Montaner, Ko Ishikawa, Alberto Camacho, Nuria Barbarroja, Stephen O’Rahilly, Jaswinder K Sethi, Joaquin Dopazo, Matej OreΕ‘ič, Mercedes Ricote, Antonio Vidal-Pui
  • JournalΒ  Β  :American Diabetes Association
  • YearΒ  Β  Β  Β  Β :2011

Role of glutamate transporters in the clearance and release of glutamate during ischemia and its relation to neuronal death

    • AuthorsΒ  Β : Alberto Camacho, Lourdes Massieu
    • JournalΒ  Β  : Archives of medical research
    • YearΒ  Β  Β  Β  Β :2006

Effect of quinolinic acid on endogenous antioxidants in rat corpus striatum

  • AuthorsΒ  Β : Erika Rodrı́guez-Martı́nez, Alberto Camacho, Perla D Maldonado, JosΓ© Pedraza-Chaverrı́, Daniel Santamarı́a, Sonia GalvΓ‘n-Arzate, Abel Santamarı́a
  • JournalΒ  Β  : Brain research
  • YearΒ  Β  Β  Β  Β :2000

In vivo hydroxyl radical formation after quinolinic acid infusion into rat corpus striatum

  • AuthorsΒ  Β :Abel SantamarΓ­a, MarΓ­a E JimΓ©nez-Capdeville, Alberto Camacho, Erika RodrΓ­guez-MartΓ­nez, Abigail Flores, Sonia GalvΓ‘n-Arzate
  • JournalΒ  Β  Β :Neuroreport
  • YearΒ  Β  Β  Β  Β :2001

Microglia activation due to obesity programs metabolic failure leading to type two diabetes

  • AuthorsΒ  Β : R Maldonado-Ruiz, L Montalvo-MartΓ­nez, Lizeth Fuentes-Mera, A Camacho
  • JournalΒ  Β  : Nutrition & diabetes
  • YearΒ  Β  Β  Β  Β :2017

Dr. ANTHOULA LAZARIS| Precision Medicine|Best Researcher Award

Published on by Top Pharmaceutical

Dr. ANTHOULA LAZARIS, Precision Medicine,Best Researcher Award

Dr. ANTHOULA LAZARIS, at MCGILL UNIV. HEALTH CTR,Canada

PROFILE

scopus

πŸ“š Early Academic Pursuits :

Anthoula Lazaris began her academic journey with a B.Sc. in Microbiology and Immunology from McGill University (1983-1986), where she developed a solid foundation in the biological sciences. She continued at McGill, earning a Ph.D. in Biochemistry from the Faculty of Medicine (1988-1992). Her postdoctoral studies took her to Leiden, The Netherlands, where she further honed her expertise in Medical Biochemistry (1992-1994). This robust educational background laid the groundwork for her illustrious career in academia and biotechnology.

🏒Professional Endeavors :

Lazaris has accumulated over 30 years of combined experience in academia and industry, holding management and senior-level positions. Currently, she is a scientist at the Research Institute of the McGill University Health Centre (RI-MUHC), focusing on metastatic and metabolic diseases with an emphasis on translational research. Her career highlights include:

  • Liver Disease Biobank: In 2011, Lazaris established a Liver Disease Biobank in collaboration with Dr. P Metrakos, collecting biospecimens from patients with liver-related diseases.
  • Quebec Extracellular Vesicle Consortium: She spearheaded this consortium with Drs. Rak and Olivier, demonstrating her leadership in collaborative research initiatives.
  • CIHR Training Grant: Lazaris co-wrote and secured a substantial CIHR training grant for the Goodman Cancer Centre, illustrating her proficiency in obtaining competitive funding.

πŸ”¬Contributions and Research Focus :

Lazaris’s research contributions span several critical areas:

  • Metastatic Disease: She focuses on colorectal cancer liver metastases (CRCLM), investigating molecular mechanisms to predict therapeutic responses and developing new biomarkers.
  • Translational Research: Her work bridges basic and clinical research, aiming to translate findings into precision therapies for cancer patients. Notably, her research on predictors of therapeutic responses to antiangiogenic agents has been groundbreaking.
  • Liver Diseases: Lazaris’s research also covers hepatocellular carcinoma, cholangiocarcinomas, and NAFLD/NASH, contributing to the broader understanding of these conditions.

πŸ†Accolades and Recognition :

Throughout her career, Lazaris has received numerous accolades:

  • Scientific American Award: In 2002, she was recognized in the category of Research Leader in Chemical and Materials for her work on transgenic animals producing spider silk.
  • Genome Canada White Paper: She spearheaded the writing of a white paper on “Disease Mechanisms,” which was integrated into Genome Quebec’s strategic plan.
  • Scientific Publications: Her research has been published in prestigious journals like Nature and Science, highlighting her contributions to molecular biology and oncology.

🌍Impact and Influence :

Lazaris’s work has had a profound impact on both the scientific community and public health:

  • Innovations in Biotechnology: She was part of the team that demonstrated the first expression of soluble spider silk, which can be spun into fibers with remarkable mechanical properties.
  • Transgenic Research Network: As the Executive Director of the Quebec Transgenic Research Network, Lazaris unified the capabilities of researchers across Quebec, securing significant funding and fostering collaborative research.
  • Cloned Animals: She was part of the team that generated the world’s first cloned goat and Canada’s first large transgenic animal, showcasing her pioneering contributions to genetic engineering.

🌟Legacy and Future Contributions :

Anthoula Lazaris’s legacy is marked by her pioneering research, leadership in collaborative scientific endeavors, and significant contributions to translational medicine. Her work continues to influence the fields of molecular biology, biotechnology, and cancer research. Looking forward, Lazaris is expected to further her contributions to personalized medicine, leveraging her extensive experience and innovative approach to address pressing challenges in healthcare. Her dedication to translational research and collaborative spirit ensures that her impact will be felt for years to come.

πŸŽ“PublicationΒ 

Predictive biomarker discovery in cancer using a unique AI model based on set theory

Hepatic stellate cell stearoyl co-A desaturase activates leukotriene B4 receptor 2 – Ξ²-catenin cascade to promote liver tumorigenesis

    • Authors :Sinha, S., Aizawa, S., Nakano, Y., … Guccione, E., Tsukamoto, H.
    • JournalΒ  Β :Nature Communications
    • YearΒ  Β  Β  Β : 2023

Targeting Liver Metastases to Potentiate Immunotherapy in MS-Stable Colorectal Cancerβ€”A Review of the Literature

  • AuthorsΒ  :, Zlotnik, O., Krzywon, L., Bloom, J., … Lazaris, A., Metrakos, P.
  • JournalΒ  Β  :Cancers
  • YearΒ  Β  Β  Β  Β :Β  2023

Isolation of extracellular vesicles from human plasma samples: The importance of controls

  • AuthorsΒ  :Tsamchoe, M., Petrillo, S., Lazaris, A., Metrakos, P.
  • JournalΒ  Β : Biotechnology Journal
  • YearΒ  Β  Β  Β  :Β  Β 2023

A Retrospective Study on the Role of Metformin in Colorectal Cancer Liver Metastases

  • AuthorsΒ  :Rada, M., Krzywon, L., Petrillo, S., Lazaris, A., Metrakos, P.
  • JournalΒ  Β : BiotechnologyΒ 
  • YearΒ  Β  Β  Β  :Β  2023

Assist Prof Dr.Francesco Asnica, Personalized Medicine,Best Researcher Award

Published on by Top Pharmaceutical

Assist Prof Dr.Francesco Asnica,Personalized Medicine ,Best Researcher Award

Assist Prof Dr.Francesco Asnica, at Department CIBIO, University of TrentDepartment CIBIO, University of Trento,Italy

Author Profile

 

Education

  • Ph.D. in Information Technology – Transdisciplinary Programme in Computational Biology (cum laude), University of Trento, Italy (May 2019)
    • Thesis: “A phylogenetic framework for large-scale analysis of microbial communities”
    • Supervisors: Prof. Enrico Blanzieri and Prof. Nicola Segata
  • Master of Science in Computer Science, University of Trento, Italy (October 2014)
    • Thesis: “PhyloPhlAn2 and GraPhlAn: novel reconstruction and visualization tools for large-scale whole-genome phylogenomics”
    • Supervisors: Prof. Enrico Blanzieri and Prof. Nicola Segata
  • Bachelor of Science in Computer Science, University of Trento, Italy (March 2012)
    • Thesis: “Installazione e Test di Estensioni Grafiche Real-time per Debian GNU/Linux”
    • Supervisor: Prof. Luca Abeni

Awards and Honors

  • Highly Cited Researcher 2023 & 2022 in Cross-Field by Clarivateβ„’
  • Member of the Gruppo 2003 per la Ricerca Scientifica since 2023
  • Euregio Young Researcher Award 2022 (Second Place)
  • Co-recipient of the X PRÊMIO 2019 – PrΓͺmio Octavio Frias de Oliveira
  • Doctor Darwin Prize 2017

Fellowships & Scholarships

  • Travel Grant for BITS 2018
  • Summer School Grant for the Second European Summer School on Nutrigenomics 2016
  • Travel Scholarship for ISMB/ECCB 2015

Invited Talks

Dr. Asnicar has delivered numerous invited talks at prestigious conferences and symposiums, including:

  • 9th Central European Congress of Life Sciences Eurobiotech 2024
  • 10th International Human Microbiome Consortium Congress 2024
  • IBS Days 2024
  • DF/HCC Microbiome Symposium Workshop 2024
  • 6th HCMPH Annual Symposium – Microbiome and Cancer 2024

Organized Workshops

  • Workshop on Data Standards, Interoperability, and Model Organisms in Microbiome Research (2023)
  • Workshop on Establishing Consensus for Microbiome Analysis Standards (2023)

πŸŽ“Publication Top Noted:

Paper Title : QIIME 2: reproducible, interactive, scalable, and extensible microbiome data science. PeerJ

  • Authors: Evan Bolyen, Jai Ram Rideout, Matthew R Dillon, Nicholas A Bokulich, Christian Abnet, Gabriel A Al-Ghalith, H Alexander, EJ Alm, M Arumugam, F Asnicar, Y Bai, JE Bisanz, K Bittinger, A Brejnrod, CJ Brislawn, CT Brown, BJ Callahan, AM Caraballo-RodrΓ­guez, J Chase, JG Caporaso
  • Journal:Inc
  • Year: 2018
Paper Title : Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals
    • Authors : Β Francesco Asnicar, Sarah E Berry, Ana M Valdes, Long H Nguyen, Gianmarco Piccinno, David A Drew, Emily Leeming, Rachel Gibson, Caroline Le Roy, Haya Al Khatib, Lucy Francis, Mohsen Mazidi, Olatz Mompeo, Mireia Valles-Colomer, Adrian Tett, Francesco Beghini, Leonard Dubois, Davide Bazzani, Andrew Maltez Thomas, Chloe Mirzayi, Asya Khleborodova, Sehyun Oh, Rachel Hine, Christopher Bonnett, Joan Capdevila, Serge Danzanvilliers, Francesca Giordano, Ludwig Geistlinger, Levi Waldron, Richard Davies, George Hadjigeorgiou, Jonathan Wolf, JosΓ© M OrdovΓ‘s, Christopher Gardner, Paul W Franks, Andrew T Chan, Curtis Huttenhower, Tim D Spector, Nicola Segata
    • Journal:Nature medicine
    • Year: 2021
Paper Title :Human postprandial responses to food and potential for precision nutrition
  • Authors: Sarah E Berry, Ana M Valdes, David A Drew, Francesco Asnicar, Mohsen Mazidi, Jonathan Wolf, Joan Capdevila, George Hadjigeorgiou, Richard Davies, Haya Al Khatib, Christopher Bonnett, Sajaysurya Ganesh, Elco Bakker, Deborah Hart, Massimo Mangino, Jordi Merino, Inbar Linenberg, Patrick Wyatt, Jose M Ordovas, Christopher D Gardner, Linda M Delahanty, Andrew T Chan, Nicola Segata, Paul W Franks, Tim D Spector
  • Journal:Nature medicine
  • Year:2020
Paper Title :Strain-level microbial epidemiology and population genomics from shotgun metagenomics
  • Authors: Matthias Scholz, Doyle V Ward, Edoardo Pasolli, Thomas Tolio, Moreno Zolfo, Francesco Asnicar, Duy Tin Truong, Adrian Tett, Ardythe L Morrow, Nicola Segata
  • Journal:Nature methods
  • Year: 2016

Paper Title :Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade

  • Authors: Gladys Ferrere, Maryam Tidjani Alou, Peng Liu, Anne-GaΓ«lle Goubet, Marine Fidelle, Oliver Kepp, SylvΓ¨re Durand, Valerio Iebba, AurΓ©lie Fluckiger, Romain DaillΓ¨re, Cassandra Thelemaque, Claudia Grajeda-Iglesias, Carolina Alves Costa Silva, Fanny Aprahamian, DΓ©borah Lefevre, Liwei Zhao, Bernhard Ryffel, Emeline Colomba, Monica Arnedos, Damien Drubay, Conrad Rauber, Didier Raoult, Francesco Asnicar, Tim Spector, Nicola Segata, Lisa Derosa, Guido Kroemer, Laurence Zitvogel
  • Journal: JCI insight
  • Year: 2021

Assist Prof Dr. Lili Xu, Drug Discovery and Development ,Best Researcher Award

Published on by Top Pharmaceutical

Assist Prof Dr. Lili Xu, Drug Discovery and Development ,Best Researcher Award

Assist Prof Dr. Lili Xu, at China Pharmaceutical University,China

Author Profile

πŸŽ“ Academic and Professional Background:

Lili Xu, Ph.D., earned her degree in Pharmaceutical Chemistry and Biology from China Pharmaceutical University in 2017. She conducted postdoctoral research at the same institution until July 2021 when she was promoted to Associate Researcher. She leads two projects funded by the National Natural Science Foundation of China and two by the Natural Science Foundation of Jiangsu Province. With over 40 SCI papers and six patents, she’s received awards like the Shimadzu Young Scholar, Gold Prize of the Macedonia Invention, and Silver Prize of the Geneva Invention Award.

πŸ”¬ Research and Innovations:

Completed/Ongoing Research Projects:

  • National Natural Science Foundation of China, General Program: Screening, design, and synthesis of novel inhibitors that interfere with the formation of NEK7-NLRP3 inflammasome complexes and their application in the treatment of acute and chronic inflammation-related diseases (82173675), 2022.01~2025.12, RMB 550,000, principal investigator, ongoing.

 

  • National Natural Science Foundation of China, Youth Program: Discovery, design, synthesis, and exploration of NLRP3 inflammasome-targeted inhibitors for the treatment of non-controllable inflammatory disorders (81803354). 2019.01~2021.12, RMB 210,000, principal investigator, completed.

 

  • Natural Science Foundation of Jiangsu Province, Youth Program: Design and synthesis of NLRP3-targeted inhibitors based on skeleton reconstruction strategy, and exploration of their therapeutic effects on non-controllable inflammatory disorders (BK20180564). 2018.07~2021.06, RMB 200,000, principal investigator, completed.

 

  • Natural Science Foundation of Jiangsu Province, General Program: Discovery, design, synthesis, and activity evaluation of novel inhibitors targeting TLR4-MD2 immune-inflammatory pathway for drug addiction treatment (BK20231480). 2023-07-01~2026-06-30, RMB 100,000, principal investigator, ongoing.
  • China Postdoctoral Science Foundation, General Program: Discovery, optimization, activity evaluation, and mechanistic studies of ULK1 inhibitors (2017M620232), 2018.01~2021.01, RMB 80,000, principal investigator, completed.

 

  • Fundamental Research Funds for the Central Universities, Key Program: Discovery and validation of novel oxadiazole-based anti-inflammatory target proteins using proteomics and molecular probe technology, 2021.01~2022.12, RMB 150,000, principal investigator, ongoing.

 

  • National Natural Science Foundation of China, General Program: Discovery of ubiquitin E3 ligase Cbl-b inhibitors based on substrate-binding crucial features and exploration of their application in tumor immunotherapy (82173680), 2022.01~2025.12, RMB 550,000, ongoing, participating.

 

  • National Natural Science Foundation of China, General Program: Discovery of targeted inducers of tau protein degradation conjugates based on ubiquitin E3 ligase Keap1 and exploration of their therapeutic application in Alzheimer’s disease (81773581), 2018.01~2021.12, RMB 620,000, completed, participating.

 

  • National Natural Science Foundation of China, Youth Program: Research on the application of GNN-based Raman hotspot regulation method in drug-target interaction (81803485), 2019.01~2021.12, RMB 210,000, completed, participating.

🏭 Consultancy/Industry Projects:

  • Institutional commissioned project: Detection of drugs in urban wastewater in Jiangyin City, commissioned by the Jiangyin Public Security Bureau, RMB 69,100, principal investigator, ongoing.
  • Industry commissioned project: Joint laboratory for drug detection between China Pharmaceutical University and Jiangsu Kangda Detection Technology Co., Ltd. (co-build laboratory), RMB 200,000, principal investigator, ongoing.

πŸ“š Books Published (ISBN):

Currently, no books have been published.

πŸ’‘ Patents Published/Under Process:

As the first inventor, Lili Xu has obtained 5 granted invention patents; as the fourth inventor, she has obtained 1 granted invention patent. Patent numbers: ZL201911146468.0, ZL202110442073.6, ZL202010483840.3, ZL201910366733.X, ZL202210071005.8, ZL202210146811.7.

.

πŸŽ“Publication Top Noted:

Paper Title : Development of fentanyl-specific monoclonal antibody (mAb) to antagonize the pharmacological effects of fentanyl
    • Authors:Jun Huang, Xing-Xing Fan, Jiaxi He, Hui Pan, Run-Ze Li, Liyan Huang, Zebo Jiang, Xiao-Jun Yao, Liang Liu, Elaine Lai-Han Leung, Jian-Xing Hee
    • Journal: Oncotarget
    • Year:2016
    • Citations : 86

     

Paper Title :The NLRP3 inflammasome: a vital player in inflammation and mediating the anti-inflammatory effect of CBD
  • Authors: Chu, F.-X., Wang, X., Li, B., Xu, L.-L., Di, B.
  • Journal: Inflammation Research
  • Volume: In Press
  • Issue: In Press
  • Year: 2024
Paper Title : Protein-protein interactions and related inhibitors involved in the NLRP3 inflammasome pathway
  • Authors: Ma, Z.-Y., Jiang, C., Xu, L.-L.
  • Journal: Cytokine and Growth Factor Reviews
  • Volume: 74
  • Pages: 14–28
  • Year: 2023
Paper Title :Mechanisms of NLRP3 inflammasome activation and the development of peptide inhibitors
  • Authors: Ye, T., Tao, W.-Y., Chen, X.-Y., Di, B., Xu, L.-L.
  • Journal: Cytokine and Growth Factor Reviews
  • Volume: 74
  • Pages: 1–13
  • Year: 2023
Paper Title : A light-up fluorescence probe for wash-free analysis of Mu-opioid receptor and ligand-binding events
  • Authors: Jia, Y., Xu, L., Wang, L., Yan, F., Hu, C.
  • Journal: Analytica Chimica Acta
  • Volume: 1261
  • Pages: 341220
  • Year: 2023